Expansion Therapeutics has hired Elliot Ehrich as its chief medical officer.
Ehrich was most recently CMO and executive vice president of research and development at Alkermes (NASDAQ: [[ticker:ALKS]]). He is also a venture partner at 5am Ventures, which incubated Expansion and co-led its $55.3 million Series A financing with Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.
Expansion, based in San Diego, CA, and in Jupiter, FL, is developing small molecule drugs to target a group of genetic diseases caused by dysfunctional RNAs.
Author: Sarah de Crescenzo
Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register.
She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.
View all posts by Sarah de Crescenzo
